EGFR and non-small cell lung carcinoma: Based on a prior report by Kim [35], it can exhibit an anti-cancer effect by inhibiting the epidermal growth factor receptor (EGFR) and Wnt/β-catenin signaling in non-small cell lung cancer cells.